Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.36 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.33 |
| ▸ | ACP1 | P24666 | 2/20 | 0.33 |
| ▸ | CDC25B | P30305 | 2/20 | 0.33 |
| ▸ | AKT1 | P31749 | 2/20 | 0.32 |
| ▸ | CPT1A | P50416 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | MGAT2 | Q10469 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17307356 | 0.84 | MEN1 (0.36) | AKT1 | |
| SCHEMBL17696764 | 0.78 | SIRT2 (0.45) | MAPTPTPN1SIRT2CYP19A1ACP1 | |
| SCHEMBL21961902 | 0.78 | SIRT2 (0.45) | MAPTPTPN1SIRT2CYP19A1ACP1 | |
| SCHEMBL21961906 | 0.76 | SIRT2 (0.42) | PTPN1SIRT2CYP19A1ACP1CDC25B | |
| Undecane SCHEMBL8674618 | 0.68 | MAPT (0.59) | MAPT | |
| SCHEMBL13647772 | 0.68 | ACHE (0.37) | MAPT | |
| SCHEMBL19480582 | 0.67 | POLB (0.36) | PTPN1SIRT2ACP1CDC25B | |
| SCHEMBL112728 | 0.67 | SIRT2 (0.53) | PTPN1SIRT2ACP1CDC25B | |
| SCHEMBL10186569 | 0.67 | SIRT2 (0.53) | PTPN1SIRT2ACP1CDC25B | |
| SCHEMBL663852 | 0.67 | SIRT2 (0.53) | PTPN1SIRT2ACP1CDC25B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9278899-B2 | Method for producing 3,5-dimethyldodecanoic acid; and 4-carboxy-3,5-Dimethyl-3,5-dodecadienoic acid | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-03-08 | — | — | US | disclosed |
| US-20150344395-A1 | METHOD FOR PRODUCING 3,5-DIMETHYLDODECANOIC ACID; AND 4-CARBOXY-3,5-DIMETHYL-3,5-DODECADIENOIC ACID | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2015-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150344395-A1 | METHOD FOR PRODUCING 3,5-DIMETHYLDODECANOIC ACID; AND 4-CARBOXY-3,5-DIMETHYL-3,5-DODECADIENOIC ACID | ACMSD, DECR1, HPD | MAPT 3803/4885PTPN1 4665/4885SIRT2 3230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.